Image
|
Figure Caption
Figure 13
Quantification of lipid profiles from zebrafish injected with PBS, Infliximab, Etanercept, Tocilizumab, and CIGB-258, in the presence of CML under a high cholesterol diet (HCD). *, p < 0.05 versus PBS (CML-alone) group; **, p < 0.01 versus PBS (CML-alone) group. All zebrafish were sacrificed at 180 min post-injection of each designated drug. (A) Quantification of the total cholesterol (TC) levels of zebrafish plasma at 180 min post-injection. (B) Quantification of the triglyceride (TG) levels of zebrafish plasma at 180 min post-injection.
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Int. J. Mol. Sci.